EVH vs. CART, ULS, GLOB, ETSY, BILI, MARA, CLVT, FIVN, RNG, and ACVA
Should you be buying Evolent Health stock or one of its competitors? The main competitors of Evolent Health include Maplebear (CART), UL Solutions (ULS), Globant (GLOB), Etsy (ETSY), Bilibili (BILI), Marathon Digital (MARA), Clarivate (CLVT), Five9 (FIVN), RingCentral (RNG), and ACV Auctions (ACVA). These companies are all part of the "business services" industry.
Evolent Health (NYSE:EVH) and Maplebear (NASDAQ:CART) are both mid-cap computer and technology companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, media sentiment, community ranking, valuation, earnings, institutional ownership and dividends.
Maplebear has a net margin of 0.00% compared to Evolent Health's net margin of -5.07%. Evolent Health's return on equity of 6.90% beat Maplebear's return on equity.
Evolent Health presently has a consensus price target of $42.00, indicating a potential upside of 77.51%. Maplebear has a consensus price target of $41.60, indicating a potential upside of 21.21%. Given Evolent Health's stronger consensus rating and higher probable upside, equities research analysts plainly believe Evolent Health is more favorable than Maplebear.
Evolent Health has higher earnings, but lower revenue than Maplebear.
Evolent Health received 512 more outperform votes than Maplebear when rated by MarketBeat users. Likewise, 73.88% of users gave Evolent Health an outperform vote while only 56.36% of users gave Maplebear an outperform vote.
63.1% of Maplebear shares are held by institutional investors. 1.6% of Evolent Health shares are held by insiders. Comparatively, 36.0% of Maplebear shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
In the previous week, Maplebear had 10 more articles in the media than Evolent Health. MarketBeat recorded 12 mentions for Maplebear and 2 mentions for Evolent Health. Maplebear's average media sentiment score of 0.39 beat Evolent Health's score of 0.22 indicating that Maplebear is being referred to more favorably in the news media.
Summary
Maplebear beats Evolent Health on 8 of the 15 factors compared between the two stocks.
Get Evolent Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for EVH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding EVH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Evolent Health Competitors List
Related Companies and Tools
